Skip to content
NewsBlazeAU – Lifestyle
Author:
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
March 19, 2026
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 17, 2026
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
March 16, 2026
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 10, 2026
←
Previous Page
1
2